Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement

Tomoki Ochiai1, Luke Oakley2, Navjot Sekhon2

  • 1Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California; Department of Cardiology, Shonan Kamakura General Hospital, Kamakura, Japan.

Insights

Redo transcatheter aortic valve replacement (TAVR) with Evolut valves poses a higher risk of coronary obstruction from sinus sequestration compared to SAPIEN 3 valves. Careful CT screening is crucial, especially with low sinotubular junction height, to mitigate risks in future redo TAVR procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Imaging

Background:

  • Coronary obstruction due to sinus sequestration is a potential complication in redo transcatheter aortic valve replacement (TAVR).
  • Limited data exists on the specific risks associated with different TAV prostheses in redo TAVR procedures.

Purpose of the Study:

  • To evaluate the risk of coronary obstruction from sinus sequestration in patients undergoing redo TAVR.
  • To compare this risk between Evolut R/PRO and SAPIEN 3 valve types using post-procedural computed tomography (CT).

Main Methods:

  • Analysis of post-TAVR CT scans from 66 patients with Evolut R/PRO and 345 patients with SAPIEN 3 valves.
  • Definition of sinus sequestration risk based on prior TAV commissure level relative to the sinotubular junction (STJ) and distance between TAV and STJ.

Main Results:

  • A significantly higher CT-identified risk of sinus sequestration was observed in the Evolut R/PRO group (45.5%) compared to the SAPIEN 3 group (2.0%) (p < 0.001).
  • Specific risks for left and right coronary arteries were higher with Evolut valves (39.4% and 24.2%, respectively) versus SAPIEN 3 (2.0% and 0.6%).
  • Overlaps between prior TAV commissural posts and coronary ostia were more frequent in the Evolut group (45.2%) than the SAPIEN 3 group (11.1%) among at-risk coronary arteries.

Conclusions:

  • The risk of sinus sequestration in redo TAVR necessitates careful CT screening, particularly in patients with low STJ height.
  • TAVs designed for commissure-to-commissure alignment with native valves may reduce the risk of coronary obstruction and facilitate future leaflet laceration procedures.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
192
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
228
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
130
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
227
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
133